Laekna begins patient recruitment for LAE118 Phase I trial

Laekna has initiated patient recruitment for its Phase I clinical trial of LAE118 in China, marking a significant step in its drug development process.

What's Hot

Trader Huang Licheng Closes 10x HYPE Long Position

Warsh: Inflation Remains Too High for Federal Reserve

Moutai Buys Two Xiamen Ad Firms for RMB 146,300

Laekna begins patient recruitment for LAE118 Phase I trial

Grayscale: AI May Boost Zcash Demand for Enhanced Privacy

Tanker Attacked and Struck in Strait of Hormuz

Anthropic Seals $35 Billion Cloud Deal with Nvidia Backing

Pew Research: 35.5% of US teens employed this summer

Dell Earnings Report May Cause 11% Stock Swing This Week

Brazil Suspends Pro-Bitcoin Candidate Santos’s Campaign, Freezes Funds

Laekna begins patient recruitment for LAE118 Phase I trial

Trader Huang Licheng Closes 10x HYPE Long Position

Warsh: Inflation Remains Too High for Federal Reserve

Moutai Buys Two Xiamen Ad Firms for RMB 146,300

Grayscale: AI May Boost Zcash Demand for Enhanced Privacy

Trader Huang Licheng Closes 10x HYPE Long Position

Warsh: Inflation Remains Too High for Federal Reserve

Moutai Buys Two Xiamen Ad Firms for RMB 146,300

What's Hot

Laekna begins patient recruitment for LAE118 Phase I trial

Related Posts